Juthathip Mongkolsapaya
Overview
Explore the profile of Juthathip Mongkolsapaya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
10906
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yin Y, Liu C, Ji X, Wang Y, Mongkolsapaya J, Screaton G, et al.
Microb Biotechnol
. 2025 Mar;
18(3):e70109.
PMID: 40042439
The COVID-19 pandemic has caused unparalleled impacts on global social dynamics, healthcare systems and economies, highlighting the urgent need for effective interventions to address current challenges and future pandemic preparedness....
2.
Huhn A, Nissley D, Wilson D, Kutuzov M, Donat R, Tan T, et al.
Nat Commun
. 2025 Jan;
16(1):338.
PMID: 39746910
Key functions of antibodies, such as viral neutralisation, depend on high-affinity binding. However, viral neutralisation poorly correlates with antigen affinity for reasons that have been unclear. Here, we use a...
3.
Asor R, Olerinyova A, Burnap S, Kushwah M, Soltermann F, Rudden L, et al.
Proc Natl Acad Sci U S A
. 2024 Sep;
121(40):e2403260121.
PMID: 39298475
Cellular processes are controlled by the thermodynamics of the underlying biomolecular interactions. Frequently, structural investigations use one monomeric binding partner, while ensemble measurements of binding affinities generally yield one affinity...
4.
Duyvesteyn H, Dijokaite-Guraliuc A, Liu C, Supasa P, Kronsteiner B, Jeffery K, et al.
Structure
. 2024 Aug;
32(10):1594-1602.e6.
PMID: 39173622
BA.2.87.1 represents a major shift in the BA.2 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is unusual in having two lengthy deletions of polypeptide in the spike...
5.
Thanh T, Tu N, Nguyet L, Thuy C, Thuan N, Ny N, et al.
Int J Infect Dis
. 2024 Aug;
147:107173.
PMID: 39094762
Objectives: We studied the immunogenicity after primary and booster vaccinations of the Abdala COVID-19 vaccine, a receptor-binding domain protein subunit vaccine, in Vietnamese people by determining the level of neutralization...
6.
Nhu L, Chambers M, Chantratita N, Cheah P, Day N, Dejnirattisai W, et al.
Wellcome Open Res
. 2024 Jul;
9:181.
PMID: 39022321
A strong and effective COVID-19 and future pandemic responses rely on global efforts to carry out surveillance of infections and emerging SARS-CoV-2 variants and to act accordingly in real time....
7.
Cai Y, Diallo S, Rosenthal K, Ren K, Flores D, Dippel A, et al.
Sci Transl Med
. 2024 Jun;
16(753):eado2817.
PMID: 38924429
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in variants that can escape neutralization by therapeutic antibodies. Here, we describe AZD3152, a SARS-CoV-2-neutralizing monoclonal antibody designed...
8.
Muhlemann B, Wilks S, Baracco L, Bekliz M, Carreno J, Corman V, et al.
Sci Transl Med
. 2024 May;
16(747):eadl1722.
PMID: 38748773
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires ongoing monitoring to judge the ability of newly arising variants to escape the immune response. A surveillance system necessitates...
9.
Hunt M, Hinrichs A, Anderson D, Karim L, Dearlove B, Knaggs J, et al.
bioRxiv
. 2024 May;
PMID: 38746185
The SARS-CoV-2 genome occupies a unique place in infection biology - it is the most highly sequenced genome on earth (making up over 20% of public sequencing datasets) with fine...
10.
Liu C, Zhou D, Dijokaite-Guraliuc A, Supasa P, Duyvesteyn H, Ginn H, et al.
Cell Rep Med
. 2024 May;
5(5):101553.
PMID: 38723626
BA.2.86, a recently described sublineage of SARS-CoV-2 Omicron, contains many mutations in the spike gene. It appears to have originated from BA.2 and is distinct from the XBB variants responsible...